Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections

Author： Blasi Francesco   Tarsia Paolo   Cosentini Roberto   Cazzola Mario   Allegra Luigi  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.7, 2003-07, pp. : 1165-1177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic options for viral lower respiratory tract infections

By  

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infections

By Cazzola M.   Sanduzzi A.   Matera M.G.  

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 3, 2003-06 ,pp. : 131-145

Elsevier

Access to resources Recommend Favorite

Fluoroquinolones are effective and well tolerated in the treatment of adults with lower respiratory tract infections

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 5, 2006-05 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

Azithromycin and lower respiratory tract infections

By Blasi F   Cazzola M   Tarsia P   Cosentini R   Aliberti S   Santus P   Allegra L  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2335-2351

Informa Healthcare

Access to resources Recommend Favorite

New Developments in Antibacterial Choice for Lower Respiratory Tract Infections in Elderly Patients

By Anna Maria Ferrara   Anna Maria Fietta  

Drugs & Aging, Vol. 21, Iss. 3, 2004-01 ,pp. : 167-186

Adis International

Access to resources Recommend Favorite